Taxamairin Analogs And Methods Of Preparation And Use Thereof

Overview

HKBU has developed a technology on development, synthesis, and applications of Taxamairin compounds and their analogs as anti-cancer drugs.

  • Taxamairin Analogs And Methods Of Preparation And Use Thereof 0
Commercialisation opportunities
Non-exclusive licensing
Problem addressed

This method improves simplifies the process, reduces costs, and provides a reliable supply for research.

Innovation
  • A semi-synthetic strategy using carnosic acid is proposed as a scalable and practical approach for producing Taxamairin A, B, and their derivatives.
  • Taxamairin compounds are derived from natural sources and exhibit various biological activities, including anti-cancer properties.
Key impact
  • This method enables gram-scale production within a week, simplifies the process, and provides a reliable supply for further biological and pharmaceutical research.
Application
  • Taxamairin analogs have shown potential in treating cancers such as colon, pancreatic, lung, gastric and liver cancers.

Patent

  • China Patent Publication No.: CN 119072462 A
Hong Kong Baptist University (HKBU)

Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad. 

Pursuing research excellence is one of the priorities of the University’s Institutional Strategic Plan 2018-2028. The University keeps enhancing its capacity and strength to produce world-class research with an aim to bring significant impact to the society. 

Enquiry
Related Innovations